Drug Trial News

RSS
Takeda, Affymax announce additional peginesatide Phase 3 study results in dialysis patients

Takeda, Affymax announce additional peginesatide Phase 3 study results in dialysis patients

29 Apr 2011
MorphoSys reaches second clinical milestone with OncoMed Pharmaceuticals

MorphoSys reaches second clinical milestone with OncoMed Pharmaceuticals

29 Apr 2011
Top-line results from Pfizer's tofacitinib Phase 3 studies in RA

Top-line results from Pfizer's tofacitinib Phase 3 studies in RA

29 Apr 2011
CEL-SCI initiates Multikine Phase III trial in head and neck cancer

CEL-SCI initiates Multikine Phase III trial in head and neck cancer

28 Apr 2011
FDA approves orphan drug designation for Cytrx’s INNO-206 to treat pancreatic cancer

FDA approves orphan drug designation for Cytrx’s INNO-206 to treat pancreatic cancer

28 Apr 2011
Curis reports first quarter net loss of $6.8 million

Curis reports first quarter net loss of $6.8 million

28 Apr 2011
Positive results from Otonomy's OTO-104 Phase 1b study in Meniere's disease

Positive results from Otonomy's OTO-104 Phase 1b study in Meniere's disease

28 Apr 2011
Positive results from Shire's Vyvanse clinical trial in schizophrenia

Positive results from Shire's Vyvanse clinical trial in schizophrenia

28 Apr 2011
Novo Nordisk first quarter net profit increases 23% to DKK 4,073 million

Novo Nordisk first quarter net profit increases 23% to DKK 4,073 million

From Novo Nordisk 28 Apr 2011
Molecular Partners completes MP0112 phase I/IIa trials in wet AMD, DME

Molecular Partners completes MP0112 phase I/IIa trials in wet AMD, DME

28 Apr 2011
The Lancet publishes phase 3 clinical study data on VIVITROL for treatment of opioid dependence

The Lancet publishes phase 3 clinical study data on VIVITROL for treatment of opioid dependence

28 Apr 2011
Enrollment complete in Unigene's oral PTH Phase 2 osteoporosis study in postmenopausal women

Enrollment complete in Unigene's oral PTH Phase 2 osteoporosis study in postmenopausal women

28 Apr 2011
FDA Advisory Committee recommends approval of Merck's VICTRELIS for chronic HCV genotype 1 infection

FDA Advisory Committee recommends approval of Merck's VICTRELIS for chronic HCV genotype 1 infection

28 Apr 2011
CESAR, Saladax begin patient enrollment in paclitaxel CEPAC-TDM trial for NSCLC

CESAR, Saladax begin patient enrollment in paclitaxel CEPAC-TDM trial for NSCLC

27 Apr 2011
Children, adolescents with liver disease may not benefit from vitamin E or metformin

Children, adolescents with liver disease may not benefit from vitamin E or metformin

27 Apr 2011
BioInvent, ThromboGenics initiate TB-402 Phase IIb trial for VTE prophylaxis

BioInvent, ThromboGenics initiate TB-402 Phase IIb trial for VTE prophylaxis

27 Apr 2011
Boehringer Ingelheim initiates enrollment in BI 201335 Phase 3 clinical trial for chronic HCV

Boehringer Ingelheim initiates enrollment in BI 201335 Phase 3 clinical trial for chronic HCV

27 Apr 2011
Positive results from Sanofi-aventis and Regeneron ZALTRAP Phase III study in mCRC

Positive results from Sanofi-aventis and Regeneron ZALTRAP Phase III study in mCRC

27 Apr 2011
IQ Therapeutics completes dosing in IQNLF Phase I trial for anthrax

IQ Therapeutics completes dosing in IQNLF Phase I trial for anthrax

27 Apr 2011
Tarix begins patient enrollment for TXA127 Phase 1 study in DCBT

Tarix begins patient enrollment for TXA127 Phase 1 study in DCBT

27 Apr 2011

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback